FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

412088006: Amphotericin B liposome (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2467540018 Amphotericin B liposome (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2473690011 Amphotericin B liposome en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amphotericin B liposome (substance) Is a Amphotericin B false Inferred relationship Some
Amphotericin B liposome (substance) Is a Liposomal agent (substance) true Inferred relationship Some
Amphotericin B liposome (substance) Is a Amphotericin (substance) true Inferred relationship Some
Amphotericin B liposome (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Amphotericin B true Inferred relationship Some
Amphotericin B liposome (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antifungal true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Amphotericin (lipid formulation) 50mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B liposome (substance) Inferred relationship Some
Product containing amphotericin B liposome The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B liposome (substance) Inferred relationship Some
Amphotericin (lipid formulation) 100mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B liposome (substance) Inferred relationship Some
Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B liposome (substance) Inferred relationship Some
Amphotericin (lipid formulation) 5mg/mL suspension for injection 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B liposome (substance) Inferred relationship Some
Product containing amphotericin B liposome in parenteral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B liposome (substance) Inferred relationship Some
Amphotericin B phospholipid complex (substance) Is a False Amphotericin B liposome (substance) Inferred relationship Some
Product containing only amphotericin B liposome (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B liposome (substance) Inferred relationship Some 1
Amphotericin B liposome only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B liposome (substance) Inferred relationship Some 1
Amphotericin B cholesteryl sulfate complex (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Amphotericin B liposome (substance) Inferred relationship Some
Amphotericin B phospholipid complex (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Amphotericin B liposome (substance) Inferred relationship Some
Amphotericin B lipid complex (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Amphotericin B liposome (substance) Inferred relationship Some
Amphotericin B liposome 5 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B liposome (substance) Inferred relationship Some 1
Amphotericin B liposome 5 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B liposome (substance) Inferred relationship Some 1
Amphotericin B liposome 50 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B liposome (substance) Inferred relationship Some 1
Amphotericin B liposome 50 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B liposome (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start